Reaction

Glomerulonephritis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,413 reports · 80 co-occurring drugs

As of the last recalculation, Glomerulonephritis appears in 2,413 FAERS reports alongside 80 co-occurring drug terms. The strongest observed disproportionality signal is BASILIXIMAB (PRR 53.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Basiliximab	71	53.6	53.9
Anti-Thymocyte Globulin (Rabbit)	27	29.2	29.3
Valganciclovir Hydrochloride Powder,	28	20.0	20.1
Mycophenolate Mofetil Hydrochloride	266	18.8	18.9
Mycophenolate Mofetil	265	18.8	18.8
Valganciclovir	38	17.6	17.7
Valganciclovir Hydrochloride	38	17.6	17.7
Tacrolimus Ointment 0.1%	228	17.3	17.4
Tacrolimus Extended-Release Capsules	228	17.3	17.3
Mesna	16	16.5	16.5
Sirolimus	25	16.2	16.2
Mesna Injection	15	15.7	15.8
Tacrolimus	256	15.7	15.7
Mycophenilic Acid	34	14.3	14.4
Mycophenolic Acid	50	13.7	13.8
Imatinib	23	11.3	11.4
Daspone	12	10.7	10.7
Dapsone Gel, 5%	12	10.7	10.7
Tenofovir Disoproxil Fumarate Tablets	10	10.0	10.0
Felodipine Extended-Release Tablets	13	9.9	9.9
Felodipine	13	9.9	9.9
Dapsone	12	9.7	9.7
Raltegravir	18	9.5	9.5
Adalimumab-Aaty	48	8.9	8.9
Abacavir Sulfate	10	8.9	8.9
Methylprednisolone	135	8.9	8.9
Piperacillin And Tazobactam	13	8.8	8.8
Gentamicin Sulfate	16	8.8	8.8
Rituximab	199	8.8	8.8
Inclisiran	8	8.6	8.6
Gentamicin	13	8.6	8.6
Adalimumab-Fkjp	45	8.5	8.5
Cyclosporine	101	8.1	8.1
Ifosfamide	19	7.7	7.7
Adalimumab-Adaz	45	7.5	7.5
Piperacillin Sodium,Tazobactam Sodium	22	7.2	7.2
Vancomycin	47	7.1	7.1
Vancomycin Hydrochloride	50	6.7	6.7
Cefazolin	7	6.6	6.6
Piperacillin Sodium And Tazobactam Sodium	15	6.6	6.6
Eplerenone	9	6.1	6.1
Entecavir	8	5.9	5.9
Ganciclovir	7	5.9	5.9
Isoniazid	11	5.9	5.9
Lansoprazole	114	5.7	5.7
Ganciclovir Sodium	7	5.7	5.7
Everolimus Tablets	11	5.7	5.7
Ritonavir	18	5.3	5.3
Filgrastim	23	5.3	5.3
Sofosbuvir	12	5.3	5.3
Tenofovir Disoproxil Fumarate	20	5.3	5.3
Rifampicin	6	5.1	5.1
Ceftriaxone	19	5.0	5.0
Lamivudine	17	4.8	4.8
Cyclophosphamide Injection, Solution	94	4.7	4.7
Cyclophosphamide	94	4.7	4.7
Cyclophosphamide For Injection	94	4.7	4.7
Pitavastatin Calcium	5	4.2	4.2
Nivolumab	46	4.2	4.2
Eculizumab	26	4.2	4.2
Canakinumab	5	4.0	4.0
Bevacizumab	53	3.8	3.8
Daptomycin	4	3.7	3.7
Agalsidase Beta	4	3.7	3.7
Tafamidis	5	3.7	3.7
Ribavirin	27	3.7	3.7
Pemetrexed	9	3.6	3.6
Vemurafenib	5	3.6	3.6
Encorafenib	4	3.5	3.5
Ipilimumab	17	3.4	3.4
Atezolizumab	15	3.3	3.3
Methoxy Polyethylene Glycol-Epoetin Beta	4	3.1	3.1
Pemetrexed Disodium	13	3.0	3.0
Bendamustine Hydrochloride	4	2.9	2.9
Dasatinib	12	2.8	2.8
Isotretinoin	15	2.6	2.6
Ledipasvir And Sofosbuvir	5	2.2	2.2
Axitinib	5	2.2	2.2
Minoxidil Foam 5% (Womens)	7	1.8	1.8
Minoxidil	7	1.3	1.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.